reference/33976815

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33976815

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	e341
issn	1537-6591 1058-4838
issueIdentifier	3
pageRange	e336-e341
publicationName	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
startingPage	e336
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f238e956f42868ca50cfc79b79842edd
bibliographicCitation	Lin Y, Yue S, Yang Y, Yang S, Pan Z, Yang X, Gao L, Zhou J, Li Z, Hu L, Tang J, Wu Q, Lei S, Tian Q, Wang Y, Hao Y, Xu L, Huang Q, Zhu B, Chen Y, Chen X, Ye L. Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial. Clin Infect Dis. 2023 Feb 08;76(3):e336–41. PMID: 35666466; PMCID: PMC9214129.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_972665a431114d1e26958f2759c4e01d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38bbc1d2ebfd66282b02c50a2b32bc52 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cee1e2bf00f0bb4fbf68a4a681dba87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37665f39efb40436b8ec01e4b327b788 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c6fd896d03123f0aeb3388338df36e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ad0dafba997500d68aef2b5e670d6c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ceadea71df09eb47a0b48d6e78432b95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71f93b33128cb77f1c54652215b1febf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79a6a5752ae31307b32a23a2847e5f93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fafd8e700fccf4a754fdb724355ec147 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_209a00e11b05c0dc7ec264bc90c573ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a5127dc92202d6644eec4e2ff7cc01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35d5c300e4426e22ce8096ef4deae92b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2746d07f356431af29df5a18982e67a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1828679dd7e2d4fd255365f04a30570a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_701c2db52dffbaad3d4f85a54a505b5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e805632e371f8f0f45a0288a62c6b659 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f753ecda85d76125a39bcee02cdd541 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7445767d7b525434830006775e02a52 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0778-3311 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03c6b0789515f293edfd207f888aa6ac
date	2022-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC9214129 https://pubmed.ncbi.nlm.nih.gov/35666466 https://doi.org/10.1093/cid/ciac448
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1135 https://portal.issn.org/resource/ISSN/1537-6591 https://portal.issn.org/resource/ISSN/1058-4838
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial
discusses	http://id.nlm.nih.gov/mesh/M0001361 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0534745 http://id.nlm.nih.gov/mesh/M000683757 http://id.nlm.nih.gov/mesh/M0545702
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000086382Q000517
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000086402Q000235 http://id.nlm.nih.gov/mesh/D000914 http://id.nlm.nih.gov/mesh/D057134 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D059085 http://id.nlm.nih.gov/mesh/D000911Q000627

Total number of triples: 56.